新冠疫苗接種計劃自2月開展以來，接種率一直處於低水平，近日更有研究發現接種2針由內地及德國研發的復必泰疫苗後，抗體數量會在半年下跌，或有需要補打第3針 ...
Video Player is loading.
Current Time 0:00
Duration 0:00
Remaining Time -0:00
This is a modal window.
The media could not be loaded, either because the server or network failed or because the format is not supported.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
